Inhibrx, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Inhibrx, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q1 2024.
- Inhibrx, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$73.8M, a 68.7% decline year-over-year.
- Inhibrx, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$249M, a 73.3% decline year-over-year.
- Inhibrx, Inc. annual Operating Income (Loss) for 2023 was -$219M, a 69.8% decline from 2022.
- Inhibrx, Inc. annual Operating Income (Loss) for 2022 was -$129M, a 68.6% decline from 2021.
- Inhibrx, Inc. annual Operating Income (Loss) for 2021 was -$76.6M, a 13.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)